共 50 条
- [41] Impact of 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 (HER2) Fluorescent In-Situ Hybridization (FISH) Testing in Breast Cancer - Retrospective Study of 709 CasesLABORATORY INVESTIGATION, 2015, 95 : 67A - 67ASingh, KamaljeetTantravahi, UmadeviSteinhoff, MargaretLomme, MichelePasquariello, TereseSung, C. James
- [42] Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2078 - U148Giordano, Sharon H.Temin, SarahKirshner, Jeffrey J.Chandarlapaty, SaratCrews, Jennie R.Davidson, Nancy E.Esteva, Francisco J.Gonzalez-Angulo, Ana M.Krop, IanLevinson, JenniferLin, Nancy U.Modi, ShanuPatt, Debra A.Perez, Edith A.Perlmutter, JaneRamakrishna, NarenWiner, Eric P.
- [44] The 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for HER2 Testing in Breast Cancer increases the requirement for Reflex In Situ Hybridisation TestingJOURNAL OF PATHOLOGY, 2015, 237 : S32 - S32Tchrakian, N.Flanagan, L.Harford, J.Gannon, J.Quinn, C.
- [45] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (12) : 1345 - 1363Bartley, Angela N.Washington, Mary KayVentura, Christina B.Ismaila, NofisatColasacco, CarolBenson, Al B., IIICarrato, AlfredoGulley, Margaret L.Jain, DhanpatKakar, SanjayMackay, Helen J.Streutker, CatherineTang, LauraTroxell, MeganAjani, Jaffer A.
- [46] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical OncologyJOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 446 - +Bartley, Angela N.Washington, Mary KayColasacco, CarolVentura, Christina B.Ismaila, NofisatBenson, Al B., IIICarrato, AlfredoGulley, Margaret L.Jain, DhanpatKakar, SanjayMackay, Helen J.Streutker, CatherineTang, LauraTroxell, MeganAjani, Jaffer A.
- [47] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyAMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 (06) : 647 - 669Bartley, Angela N.Washington, Mary KayVentura, Christina B.Ismaila, NofisatColasacco, CarolBenson, Al B., IIICarrato, AlfredoGulley, Margaret L.Jain, DhanpatKakar, SanjayMackay, Helen J.Streutker, CatherineTang, LauraTroxell, MeganAjani, Jaffer A.
- [48] Impact of the updated 2018 American Society of Clinical Oncology/College of American Pathologists (ASCO/CAP) guidelines on Human Epidermal Growth Factor Receptor 2 (HER2) gene testing in invasive breast cancers: A single center studyANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 58Lim, Tse HuiLim, Alvin Soon TiongTien, Sim LengTan, Puay Hoon
- [49] HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline Summary From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical OncologyJOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (01) : 53 - +Bartley, Angela N.Washington, Mary KayIsmaila, NofisatAjani, Jaffer A.
- [50] Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2-Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineJOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (29) : 3307 - +Partridge, Ann H.Rumble, R. BryanCarey, Lisa A.Come, Steven E.Davidson, Nancy E.Di Leo, AngeloGralow, JulieHortobagyi, Gabriel N.Moy, BeverlyYee, DouglasBrundage, Shelley B.Danso, Michael A.Wilcox, MaggieSmith, Ian E.